TRAX First Tracks Biotherapeutics, Inc.

$44.04

First Tracks Biotherapeutics, Inc. (TRAX) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.83 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.6% since its last earnings release on August 12, 2026.

First Tracks Biotherapeutics Missed Consensus Estimates
Wednesday, August 12, 2026 · 4:15 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · After Close
Earnings Whisper
-
vs ($0.83)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $44.03

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology